Evidence map›Paper›PMID 34607194›Full record

Trial reportDrug and alcohol dependence2021

Do people with opioid use disorder and posttraumatic stress disorder benefit from dding Individual opioid Drug Counseling to buprenorphine?

R Kathryn McHugh, Blake T Hilton, Alexandra M Chase, Margaret L Griffin, Roger D Weiss

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

R Kathryn McHughDivision of Alcohol, Drugs and Addiction, McLean Hospital, USA; Department of Psychiatry, Harvard Medical School, USA. Electronic address: kmchugh@mclean.harvard.edu.
Blake T HiltonDivision of Alcohol, Drugs and Addiction, McLean Hospital, USA; Department of Psychiatry, Harvard Medical School, USA.
Alexandra M ChaseDivision of Alcohol, Drugs and Addiction, McLean Hospital, USA.
Margaret L GriffinDivision of Alcohol, Drugs and Addiction, McLean Hospital, USA; Department of Psychiatry, Harvard Medical School, USA.
Roger D WeissDivision of Alcohol, Drugs and Addiction, McLean Hospital, USA; Department of Psychiatry, Harvard Medical School, USA.
Harvard University · USMcLean Hospital · US

Funding

The National Drug Abuse Treatment Clinical Trials NetworkUG1DA015831 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Roger D. Weiss · 2015 to 2026
$110.8M
The National Drug Abuse Treatment Clinical Trials Network (U10)U10DA015831 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI CARROLL, KATHLEEN M., WEISS, ROGER D. · 2002 to 2015
$28.8M
Sex and Gender Differences in Response to Behavioral Strategies for Reducing Stress ReactivityR21DA046937 · NIDA · MCLEAN HOSPITAL · PI MCHUGH, REBECCA KATHRYN · 2018 to 2019
$556k
NIDA NIH HHS R21 DA046937NIDA NIH HHS U10 DA015831NIDA NIH HHS UG1 DA015831
6 · The paper itself

Abstract

background and purposeLarge randomized trials have found that behavioral therapy for opioid use disorder (e.g., Individual Drug Counseling, Cognitive Behavioral Therapy for Opioid Use Disorder) does not improve buprenorphine maintenance outcomes, on average, for individuals with opioid use disorder. However, recent studies indicate that certain subgroups of patients may benefit from the addition of behavioral therapy to buprenorphine. In particular, people with more complex and severe psychosocial needs may benefit from the addition of behavioral therapy for opioid use disorder.

methodsIn this study, we conducted a secondary analysis of a large, multi-site randomized trial (N = 357) of buprenorphine maintenance with and without individual Opioid Drug Counseling (ODC) for the treatment of opioid use disorder. We hypothesized that participants with posttraumatic stress disorder (PTSD) would benefit from the addition of ODC.

resultsLogistic regression models indicated a significant PTSD by treatment condition interaction. Specifically, 67% of those with PTSD had a successful opioid use disorder treatment outcome when they were assigned to receive both ODC and buprenorphine, compared to a 36% response rate among those who received buprenorphine alone.

conclusionsAlthough these results require replication, our findings provide initial indication that ODC is an important complement to buprenorphine maintenance treatment for people with co-occurring PTSD and opioid use disorder.

Indexed as

BuprenorphineOpioid-Related DisordersPharmaceutical PreparationsStress Disorders, Post-TraumaticAnalgesics, OpioidCounselingHumansNarcotic AntagonistsOpiate Substitution TreatmentAnalgesics, OpioidBuprenorphineNarcotic AntagonistsPharmaceutical PreparationsBehavioral therapyBuprenorphineCo-occurring disordersOpioid use disorderPosttraumatic stress disorder

Identifiers

PMID34607194
PMCPMC8595708
OpenAlexW3199572855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.